Prof. Dr. Funda Timurkaynak, MD
Timeline
Career milestones.
Scientific work
Selected peer-reviewed publications.
-
2005J Antimicrob Chemother«Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey»· senior author · 337 citations
-
2006Int J Antimicrob Agents«In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units»· first author
-
2010Clin Microbiol Infect«Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections»· co-author
-
2018J Antimicrob Chemother«Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection»· co-author
-
2016J Hosp Infect«Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality»· co-author
-
2009Braz J Infect Dis«Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance»· co-author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.